Table 4.
hFSH + PP vs. hFSH | ||||
---|---|---|---|---|
RPS26 | 6,33E-08 | 2.10 | Up | Ribosomal protein S26 |
ARRDC4 | 6,62E-04 | 1.96 | Up | Arrestin domain containing 4 |
AK3L1 | 9,39E-03 | 1.70 | Up | Adenylate kinase 3-like 1 |
IL8 | 1,88E-06 | 3.16 | Down | Interleukin 8 |
FAM110C | 9,17E-03 | 2.14 | Down | Family with sequence similarity 110, member C |
CYP51A1 | 1,36E-03 | 1.95 | Down | Cytochrome P450, family 51, subfamily A, polypeptide 1 |
NAP1L5 | 1,49E-03 | 1.90 | Down | Nucleosome assembly protein 1-like 5 |
C19orf12 | 3,82E-04 | 1.86 | Down | Chromosome 19 open reading frame 12 |
TANC1 | 3,70E-03 | 1.85 | Down | Tetratricopeptide repeat, ankyrin repeat |
HMGCR | 1,39E-04 | 1.76 | Down | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
KCMF1 | 1,11E-03 | 1.71 | Down | Potassium channel modulatory factor 1 |
RBM25 | 9,56E-04 | 1.70 | Down | RNA binding motif protein 25 |
RCHY1 | 2,63E-03 | 1.60 | Down | Ring finger and CHY zinc finger domain |
ILF3 | 2,41E-03 | 1.60 | Down | Interleukin enhancer binding factor 3, 90 kDa |
ADIPOR2 | 9,05E-03 | 1.59 | Down | Adiponectin receptor 2 |
BAT2D1 | 1,87E-03 | 1.57 | Down | BAT2 domain containing 1 |
WBP11 | 6,27E-04 | 1.57 | Down | WW domain binding protein 11 |
SLC30A7 | 2,19E-05 | 1.56 | Down | Solute carrier family ZN transporter |
HIVEP3 | 2,44E-03 | 1.55 | Down | Human immunodeficiency virus type I enhancer binding protein 3 |
CUL4B | 6,22E-03 | 1.54 | Down | Cullin 4B |
EIF5 | 3,64E-03 | 1.54 | Down | Eukaryotic translation initiation factor 5 |
USP12 | 4,51E-05 | 1.54 | Down | Ubiquitin specific peptidase 12 |
KIAA1377 | 1,83E-04 | 1.54 | Down | KIAA1377 |
ZNF275 | 1,61E-03 | 1.53 | Down | Zinc finger protein 275 |
GPR56 | 5,46E-04 | 1.53 | Down | G protein-coupled receptor 56 |
The following genesAKAP2, Amigo2, HSPA1, TFRC, RSG2, WTAP, DR1, IGF1R, HTRA1 are down regulated at a significance level 0.05 < p < 0.01
Note the strong down regulation of the Zinc transporter SLC30A7 (see [38])